Zhenlin Wang Selected Research

Zhenlin Wang Research Topics

Disease

9	Neoplasms (Cancer) 07/2022 - 02/2014
5	Rhinosinusitis 04/2021 - 09/2009
4	Nasal Polyps (Nasal Polyp) 01/2021 - 09/2009
4	Chordoma 04/2019 - 01/2015
3	Carcinogenesis 01/2022 - 03/2006
3	Inflammation (Inflammations) 01/2016 - 06/2008
2	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 03/2006
2	Allergic Rhinitis 01/2021 - 10/2011
2	Lung Neoplasms (Lung Cancer) 04/2019 - 01/2019
2	Obstructive Sleep Apnea 03/2007 - 06/2006
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Colitis 01/2022
1	Ulcerative Colitis 01/2022
1	Ileus 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Sarcopenia 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Glioma (Gliomas) 01/2021
1	Thyroglossal Cyst 01/2020
1	Oncogene Addiction 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fabry Disease (Fabry's Disease) 01/2018
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018
1	Calculi (Calculus) 01/2017
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2017
1	Kidney Calculi (Kidney Stone) 01/2017
1	Osteoarthritis 07/2016
1	Type 2 Diabetes Mellitus (MODY) 06/2015
1	Sarcoma (Soft Tissue Sarcoma) 03/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2011 - 02/2009
3	Messenger RNA (mRNA)IBA 06/2022 - 01/2015
3	Brachyury protein (Brachyury)IBA 01/2019 - 01/2015
2	Circular RNAIBA 01/2022 - 01/2021
2	LipopolysaccharidesIBA 01/2022 - 10/2015
2	CateninsIBA 01/2022 - 01/2019
2	Long Noncoding RNAIBA 01/2019 - 07/2016
2	Transcription Factors (Transcription Factor)IBA 12/2016 - 01/2015
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2015 - 01/2015
2	Protein Isoforms (Isoforms)IBA 10/2015 - 01/2015
2	p38 Mitogen-Activated Protein KinasesIBA 01/2015 - 10/2011
2	NF-kappa B (NF-kB)IBA 10/2009 - 09/2009
2	Dinoprostone (PGE2)FDA Link 02/2009 - 06/2008
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Interferon Regulatory FactorsIBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	CytokinesIBA 04/2021
1	ChemokinesIBA 04/2021
1	LigandsIBA 04/2021
1	AlbuminsIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	ProcollagenIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	AndrogensIBA 01/2021
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 04/2019
1	AlkaloidsIBA 04/2019
1	GlycosidesIBA 04/2019
1	beta-solamarineIBA 04/2019
1	Tumor Necrosis FactorsIBA 04/2019
1	SteroidsIBA 04/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA 01/2019
1	Glycogen Synthase Kinase 3 betaIBA 01/2019
1	ParaffinIBA 01/2019
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019
1	BP-1-102IBA 01/2019
1	GadoliniumIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 12/2016
1	Matrix Metalloproteinases (MMPs)IBA 07/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	TitaniumIBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2015
1	ORALIT (ORS)IBA 03/2015
1	EnzymesIBA 01/2015
1	VaccinesIBA 02/2014

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2006
2	Radiofrequency Ablation 01/2020 - 05/2015
1	Drug Therapy (Chemotherapy) 07/2022
1	Length of Stay 01/2022
1	Cystectomy 01/2022
1	Castration 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2021
1	Denervation 01/2021
1	Conservative Treatment 01/2021
1	Molecular Targeted Therapy 01/2021
1	Chemoradiotherapy 01/2021
1	Surgical Amputation (Amputations) 01/2021
1	Endoscopes 01/2020
1	Laryngoscopes 01/2020
1	Percutaneous Nephrolithotomy 01/2017